Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
LA01 - IASLC Lectureship Award Session
- 13:30 - 15:00
- 9/26/2018
- Location: Room 105
- Type: Lectureship Award Session
- Track:
-
+
LA01.01 - Clifton F. Mountain Lectureship Award for Staging - Is There Still a Stage for Improvements in Staging?
13:30 - 13:40 | Presenter: Johan F. Vansteenkiste
- Abstract
No abstract available for this presentation
-
+
LA01.02 - IASLC Lectureship Award for Radiation Oncology - Defining the Role of Radiotherapy for Lung Cancer: Past, Present and Future
13:40 - 13:50 | Presenter: Hak Choy
- Abstract
No abstract available for this presentation
-
+
LA01.03 - Heine H. Hansen Lectureship Award for Small Cell Lung Cancer - New Opportunities in Small Cell Lung Cancer
13:50 - 14:00 | Presenter: Charles M. Rudin
- Abstract
No abstract available for this presentation
-
+
LA01.04 - Adi F. Gazdar Lectureship Award for Translational Research - Genomic Alterations in Human Lung Cancers
14:00 - 14:10 | Presenter: Matthew Meyerson
- Abstract
No abstract available for this presentation
-
+
LA01.05 - Tsuguo Naruke Lectureship Award for Surgery - The Value of Naruke Lymph Node Chart and the Creation of IASLC Chart in Lung Cancer
14:10 - 14:20 | Presenter: Hisao Asamura
- Abstract
No abstract available for this presentation
-
+
LA01.06 - Daniel C. Ihde Lectureship Award for Medical Oncology - The Intersection of Science and Medicine
14:20 - 14:30 | Presenter: David P Carbone
- Abstract
No abstract available for this presentation
-
+
LA01.07 - Robert J. Ginsberg Lectureship Award for Surgery - Honoring the Tradition of Surgically-Based Clinical Trials
14:30 - 14:40 | Presenter: Valerie W Rusch
- Abstract
No abstract available for this presentation
-
+
LA01.08 - IASLC Lectureship Award for Nursing and Allied Health Professionals - The Right Hand: The Art of Collaboration
14:40 - 14:50 | Presenter: Kimberly Ann Rohan
- Abstract
No abstract available for this presentation
-
+
LA01.09 - Q&A
14:50 - 15:00
- Abstract
No abstract available for this presentation
-
+
MA25 - Oligometastasis: Defining, Treating, and Evaluating
- 13:30 - 15:00
- 9/26/2018
- Location: Room 203 BD
- Type: Mini Oral Abstract Session
- Track: Oligometastatic NSCLC
-
+
MA25.01 - EORTC Lung Cancer Group Survey to Define Synchronous Oligometastatic Disease in NSCLC
13:30 - 13:35 | Presenter: Lizza Hendriks | Author(s): Antonin Levy, Thierry Berghmans, Corinne Faivre-Finn, Matteo Giaj Levra, Niccolo Giaj-Levra, Baktiar Hasan, Nicolas Girard, Laurent Greillier, Sylvie Lantuejoul, John G Edwards, Mary O’brien, Martin Reck, Benjamin Besse, Silvia Novello, Anne-Marie C. Dingemans
- Abstract
Loading... -
+
MA25.02 - Searching for a Definition of Synchronous Oligometastatic (sOMD)-NSCLC: A Consensus from Thoracic Oncology Experts
13:40 - 13:45 | Presenter: Anne-Marie C. Dingemans | Author(s): Lizza Hendriks, Thierry Berghmans, Antonin Levy, Baktiar Hasan, Corinne Faivre-Finn, Matteo Giaj Levra, Niccolo Giaj-Levra, Nicolas Girard, Laurent Greillier, Sylvie Lantuejoul, John G Edwards, Mary O’brien, Martin Reck, Egbert F Smit, Paul Emile Van Schil, Pieter E. Postmus, Sara Ramella, Yolande Lievens, Mina Gaga, Nir Peled, Giorgio Vittorio Scagliotti, Suresh Senan, Luis Paz-Ares, Matthias Guckenberger, Fiona McDonald, Simon Ekman, Tanja Cufer, Hester Gietema, Maurizio Infante, Rafal Dziadziuszko, Benjamin Besse, Silvia Novello
- Abstract
Loading... -
+
MA25.03 - Defining Oligometastatic Non-Small Cell Lung Cancer (NSCLC): An Evolving Multidisciplinary Expert Opinion
13:35 - 13:40 | Presenter: Lizza Hendriks | Author(s): Christophe A. Dooms, Thierry Berghmans, Silvia Novello, Antonin Levy, Dirk De Ruysscher, Baktiar Hasan, Matteo Giaj Levra, Niccolo Giaj-Levra, Benjamin Besse, Johan F. Vansteenkiste, Anne-Marie C. Dingemans
- Abstract
Loading... -
+
MA25.04 - Discussant - MA 25.01, MA 25.02, MA 25.03
13:45 - 14:00 | Presenter: Abraham J. Wu
- Abstract
No abstract available for this presentation
-
+
MA25.05 - Characteristics & Survival of Resected Stage IV Non-Small Cell Lung Cancer (NSCLC) in the Mid-South Quality of Surgical Resection Cohort
14:00 - 14:05 | Presenter: Nicholas R. Faris | Author(s): Yu-Sheng Lee, Matthew P Smeltzer, Meredith A Ray, Carrie L Fehnel, Cheryl Houston-Harris, Olawale Akinbobola, Philip Ojeabulu, Edward Owen, Richard Eubanks, Hector Dox, David Talton, Ganpat Valaulikar, Horace Lynn Wiggins, Bradley Wolf, Paul Steven Levy, Edward Todd Robbins, Raymond U. Osarogiagbon
- Abstract
Loading... -
+
MA25.06 - RPA Analysis for Oligometastatic Non-Small Cell Lung Cancer: Smoking Combine T3/4 Patients May Not Be Benefit from Local Consolidative Treatment
14:05 - 14:10 | Presenter: Jia-Tao Zhang | Author(s): Yi-Chun Tang, Si-Yang Liu, Song Dong, Xue-Ning Yang, Yi-Long Wu, Wen-Zhao Zhong
- Abstract
Loading... -
+
MA25.07 - Effectiveness of Systemic Therapy Combined with Thoracic Radiotherapy for Patients with Oligometastatic NSCLC: A Pooled Analysis
14:10 - 14:15 | Presenter: Chunyu Wang | Author(s): Jingbo Wang, Xiaotong Lu, Luhua Wang
- Abstract
Loading... -
+
MA25.08 - Discussant - MA 25.05, MA 25.06, MA 25.07
14:15 - 14:30 | Presenter: Alysa Fairchild
- Abstract
No abstract available for this presentation
-
+
MA25.09 - M1b Disease in the 8th Edition of IASLC Staging of Lung Cancer: Pattern of Single Extrathoracic Metastasis and Clinical Outcom
14:30 - 14:35 | Presenter: Hyesun Park | Author(s): Christine A Lydon, Tetsuro Araki, Hiroto Hatabu, Michael Rabin, Bruce E Johnson, Mizuki Nishino
- Abstract
Loading... -
+
MA25.10 - Complete Response by PET-CT After Radical Treatment in Oligometastatic Non-Small Cell Lung Cancer Predicts Longer Survival
14:35 - 14:40 | Presenter: Oscar Arrieta | Author(s): Luis Antonio Cabrera-Miranda, Feliciano Barron, Zyanya Lucia Zatarain-Barrón, Laura-Alejandra Ramírez-Tirado, Miguel Angel Salinas Padilla, Jose Francisco Corona-Cruz, Andrés F. Cardona, Manuel Arguelles, Federico Maldonado, Monica Blake, Edgardo Jiménez-Fuentes, Osvaldo Aren
- Abstract
Loading... -
+
MA25.11 - Clinical and Molecular Predictors of Outcome in Patients with EGFR mutant NSCLC Brain Metastases treated with RT
14:40 - 14:45 | Presenter: Fabio Y Moraes | Author(s): Jessica Weiss, Mor Moskovitz, Hadas Sorotsky, Melania Pintilie, Natasha B Leighl, Penelope Bradbury, Geoffrey Liu, Gelareh Zadeh, Mark K. Doherty, Alborz Kia, Jonathan So, Michael Cabanero, Trevor J. Pugh, Vijithan Sugumar, Dax Torti, Ming Sound Tsao, Jonathon Torchia, David B Shultz, Frances A Shepherd, Benjamin H Lok
- Abstract
Loading... -
+
MA25.12 - Discussant - MA 25.09, MA 25.10, MA 25.11
14:45 - 15:00 | Presenter: Michael Macmanus
- Abstract
No abstract available for this presentation
-
+
MA26 - New Therapies and Emerging Data in ALK, EGFR and ROS1
- 13:30 - 15:00
- 9/26/2018
- Location: Room 201 BD
- Type: Mini Oral Abstract Session
- Track: Targeted Therapy
-
+
MA26.01 - Accumulation of Concomitant Mutations Involved in Drug Resistance in the Sequential ALK TKI Treatments of ALK-Positive NSCLC
13:30 - 13:35 | Presenter: Shun Lu | Author(s): Yongfeng Yu, Yan Ding, Xue Wu, Hairong Bao, Yang W. Shao
- Abstract
Loading... -
+
MA26.02 - Upfront or Sequential Strategy for New Generation Anaplastic Lymphoma Kinase (ALK) Inhibitors: An Italian Retrospective Study.
13:35 - 13:40 | Presenter: Elisa Gobbini | Author(s): Pamela Pizzutilo, Rita Chiari, Sara Pilotto, Claudio Dazzi, Giorgia Osman, Paola Bordi, Laura Ghilardi, Fabiana Letizia Cecere, Paolo Graziano, Evaristo Maiello, Gloria Borra, Olga Martelli, Vanesa Gregorc, Vieri Scotti, Clelia Casartelli, Ferdinando Riccardi, Piero Rizzo, Alessandro Del Conte, Angelo Delmonte, Claudia Bareggi, Diego Cortinovis, Concetta Sergi, Antonio Rossi, Giulio Rossi, Emilio Bria, Massimo Di Maio, Silvia Novello
- Abstract
Loading... -
+
MA26.03 - Activity of Osimertinib and the Selective RET Inhibitor BLU-667 in an EGFR-Mutant Patient with Acquired RET Rearrangement
13:40 - 13:45 | Presenter: Zofia Piotrowska | Author(s): H Isozaki, JK Lennerz, Subba Digumarthy, Justin F Gainor, Nicolas Marcoux, M Banwait, D Dias-Santagata, A. John Iafrate, Mari Mino-Kenudson, Rebecca J Nagy, Richard B Lanman, E Evans, C Clifford, B Wolf, AN Hata, Lecia Sequist
- Abstract
Loading... -
+
MA26.04 - Discussant - MA 26.01, MA 26.02, MA 26.03
13:45 - 14:00 | Presenter: Caroline McCoach
- Abstract
No abstract available for this presentation
-
+
MA26.05 - Comprehensive Analysis of Treatment Response and Progression Pattern in Chinese Patients with Different ALK Fusion-Variants
14:00 - 14:05 | Presenter: Meng Qiao | Author(s): Chao Zhao, Xuefei Li, Tao Jiang, Fengying Wu, Xiaoxia Chen, Chunxia Su, Caicun Zhou
- Abstract
Loading... -
+
MA26.06 - Crizotinib-Treated ALK Immunopositive Metastasized NSCLC is Associated with an Unfavorable Prognosis when FISH Negative
14:05 - 14:10 | Presenter: Erik Thunnissen | Author(s): Birgit Lissenberg-Witte, Michel Van Den Heuvel, Kim Monkhorst, Birgit G Skov, Jens B Sorensen, Anders Mellemgaard, Anne-Marie C. Dingemans, ErnstJan Speel, Joop de Langen, Sayed MS Hashemi, Idris Bahce, Miep Van Der Drift, Reinhard Büttner, Monika Looijen_salomon, John Roy Gosney, Pieter E. Postmus, Suzi Samii, Fabrice Duplaquet, Brigit Weynand, Xavier Durando, Frederique Penault-Llorca, Stephen P Finn, Buge Aysim Oz, Nalan Akyurek, Jürgen Wolf, Lukas Bubendorf, Annemieke Hiemstra, Sylvia Duin, Ivonne Marondel, Wim Timens, Ed MD Schuuring, Patrick Pauwels, Egbert F Smit
- Abstract
Loading... -
+
MA26.07 - ROS1 (SP384) Immunohistochemistry Inter-Reader Precision Between 12 Pathologists
14:10 - 14:15 | Presenter: Keith M Kerr | Author(s): Amy Elizabeth Hanlon Newell, Wen-Wei Liu, Lukas Bubendorf, Reinhard Büttner, Mark Kockx, Myriam Kossai, Fernando Lopez-Rios, Antonio Marchetti, Ivonne Marondel, Andrew G Nicholson, Buge Aysim Oz, Patrick Pauwels, Frederique Penault-Llorca, Giulio Rossi, Vanessa Rüsseler, Erik Thunnissen, Greg Pate, Bryce Portier, Claire Faure, Catherine H Le, Derek Smith, Ina Menzl, Richard S.P. Huang
- Abstract
Loading... -
+
MA26.08 - Discussant - MA 26.05, MA 26.06, MA 26.07
14:15 - 14:30 | Presenter: Dong-Wan Kim
- Abstract
No abstract available for this presentation
-
+
MA26.09 - Lazertinib, a Third Generation EGFR-TKI, in Patients with EGFR-TKI-Resistant NSCLC: Updated Results of a Phase I/II Study
14:30 - 14:35 | Presenter: Byoung Chul Cho | Author(s): Ji-Youn Han, Sang-We Kim, Ki-Hyeong Lee, Dong-Wan Kim, Yun-Gyoo Lee, Gyeong-Won Lee, Jong-Seok Lee, Eun Kyung Cho, Joo-Hang Kim, Sung Sook Lee, Young Joo Min, Jin-Soo Kim, Sang Won Shin, Hye Ryun Kim, Min Hee Hong, Jin Seok Ahn, Seonmi Kang, Sohee Kim, Seong Bok Jang, Soongyu Choi, Myung-Ju Ahn
- Abstract
Loading... -
+
MA26.10 - CNS Activity of Ramucirumab in Combination with Osimertinib in Patients with Advanced T790M-Positive EGFR-Mutant NSCLC
14:35 - 14:40 | Presenter: Luis Paz-Ares | Author(s): David Planchard, James Chih-Hsin Yang, Ki Hyeong Lee, Pilar Garrido, Keunchil Park, Joo-Hang Kim, Dae Ho Lee, Huzhang Mao, Bo H Chao, Helena Yu
- Abstract
Loading... -
+
MA26.11 - Effects of Dose Modifications on the Safety and Efficacy of Dacomitinib for EGFR Mutation-Positive NSCLC
14:40 - 14:45 | Presenter: Yi-Long Wu | Author(s): Tony S. Mok, Kazuhiko Nakagawa, Rafael Rosell, Ki Hyeong Lee, Jesus Corral, Maria Rita Migliorino, Adam Pluzanski, Rolf Linke, Geeta Devgan, Eric I. Sbar, Susan Quinn, Tao Wang
- Abstract
Loading... -
+
MA26.12 - Discussant - MA 26.09, MA 26.10, MA 26.11
14:45 - 15:00 | Presenter: Liza Villaruz
- Abstract
No abstract available for this presentation
-
+
MA27 - Novel Drugs and PDX Models
- 13:30 - 15:00
- 9/26/2018
- Location: Room 206 BD
- Type: Mini Oral Abstract Session
- Track: Targeted Therapy
-
+
MA27.01 - Establishment of PDX From Tumors Characterized by EGFR Mutations or ALK Fusion Genes from Resections, Biopsies and Pleural Fluids
13:30 - 13:35 | Presenter: Sebastiao Martins-Filho | Author(s): Michael Cabanero, Nhu-An Pham, Erin L Stewart, Deepti Ravi, Devalben Patel, Judy McConnell, Alexandria Grindlay, Frances Allison, Ming Li, Frances A Shepherd, Ming Sound Tsao, Kazuhiro Yasufuku, Geoffrey Liu
- Abstract
Loading... -
+
MA27.02 - Hypofractionated Radiotherapy Normalizes Tumor Vasculature in Non-Small Cell Lung Cancer Xenografts Through p-STAT3/HIF-1 Alpha Pathway
13:35 - 13:40 | Presenter: Xiaorong Dong | Author(s): Xiong Chun Jin, Fan Tong, Chunhua Wei, Hui Lu
- Abstract
Loading... -
+
MA27.03 - Multi-Omic Characterization of TKI-Treated Drug-Tolerant Cell Population in an EGFR-Mutated NSCLC Primary-Derived Xenograft
13:40 - 13:45 | Presenter: Erin L Stewart | Author(s): Michael Cabanero, Vibha Raghavan, Jeffrey Bruce, Paul Guilhamon, Rajat Singhania, Nhu-An Pham, Shu Yi Shen, Tiantian Li, Ming Li, Natasha B Leighl, Frances A Shepherd, Trevor J. Pugh, Daniel De Carvalho, Mathieu Lupien, Geoffrey Liu, Ming Sound Tsao
- Abstract
Loading... -
+
MA27.04 - Discussant - MA 27.01, MA 27.02, MA 27.03
13:45 - 14:00 | Presenter: Byoung Chul Cho
- Abstract
No abstract available for this presentation
-
+
MA27.05 - Drug Loaded Mesenchymal Stem Cells for Targeted Lung Cancer Treatment in Mice
14:00 - 14:05 | Presenter: YAOJIONG Wu | Author(s): Xusheng Wang
- Abstract
Loading... -
+
MA27.06 - Therapeutic Silencing of Oncogenic KRAS With a Mutant-Specific Short Interfering RNA
14:05 - 14:10 | Presenter: Chad Victor Pecot | Author(s): Amanda Van Swearingen, Bjoern Papke
- Abstract
Loading... -
+
MA27.07 - Lung Adenocarcinoma Harboring BRAF G469V Mutation is Uniquely Sensitive to EGFR Tyrosine Kinase Inhibitors
14:10 - 14:15 | Presenter: Hirotsugu Notsuda | Author(s): Nhu-An Pham, Ming Li, Ni Liu, Vibha Raghavan, Zhenhao Fang, Christopher B Marshall, Nadeem Moghal, Mitsuhiko Ikura, Ming Sound Tsao
- Abstract
Loading... -
+
MA27.08 - Discussant - MA 27.05, MA 27.06, MA 27.07
14:15 - 14:30 | Presenter: Gwyn Bebb
- Abstract
No abstract available for this presentation
-
+
MA27.09 - Dual Inhibition of BCL-XL and MCL-1 is Required to Induce Tumour Regression in Lung Squamous Cell Carcinomas Sensitive to FGFR Inhibition
14:30 - 14:35 | Presenter: Marie-Liesse Asselin-Labat | Author(s): Clare E Weeden, Casey Ah-Cann, Aliaksei Holik, Delphine Merino, Guillaume Lessene
- Abstract
Loading... -
+
- Abstract
Loading... -
+
MA27.11 - Genomic Sequencing and Editing Revealed the GRM8 Signaling Pathway as Potential Therapeutic Targets of Squamous Cell Lung Cancer
14:40 - 14:45 | Presenter: Panpan Zhang | Author(s): Shaolei Li, Yue Yang
- Abstract
Loading... -
+
MA27.12 - Discussant - MA 27.09, MA 27.10, MA 27.11
14:45 - 15:00 | Presenter: Dave Barbie
- Abstract
No abstract available for this presentation
-
+
MS28 - IO Combinations in Advanced NSCLC
- 13:30 - 15:00
- 9/26/2018
- Location: Room 106
- Type: Mini Symposium
- Track: Immunooncology
-
+
MS28.01 - Understanding the Rationale for Combining IO Agents
13:30 - 13:45 | Presenter: Edward B Garon
- Abstract
No abstract available for this presentation
-
+
MS28.02 - Combination IO+IO
13:45 - 14:00 | Presenter: Myung-Ju Ahn
- Abstract
No abstract available for this presentation
-
+
MS28.03 - Combinatorial IO + Chemo
14:00 - 14:15 | Presenter: Rosalyn Juergens
- Abstract
No abstract available for this presentation
-
+
MS28.04 - Combination with Targeted Therapies
14:15 - 14:30 | Presenter: Ross Soo
- Abstract
No abstract available for this presentation
-
+
MS28.05 - Combining IO with Radiation
14:30 - 14:45 | Presenter: Corinne Faivre-Finn
- Abstract
No abstract available for this presentation
-
+
MS28.06 - Q&A
14:45 - 15:00
- Abstract
No abstract available for this presentation
-
+
MS29 - Selection into Screening Programs: Interplay of Risk Algorithms, Genetic Markers and Biomarkers
- 13:30 - 15:00
- 9/26/2018
- Location: Room 206 F
- Type: Mini Symposium
- Track: Screening and Early Detection
-
+
MS29.00 - Introduction with Poll Slides
13:30 - 13:35 | Presenter: Betty Tong, John R Goffin
- Abstract
No abstract available for this presentation
-
+
MS29.01 - Assessment of Risk Prediction Algorithms for Entry into Screening Programs
13:35 - 13:50 | Presenter: Martin Tammemägi
- Abstract
No abstract available for this presentation
-
+
MS29.02 - Defining Screening Frequency & Duration Using Risk Prediction Algorithms and CT Image Findings
13:50 - 14:05 | Presenter: Kevin ten Haaf
- Abstract
No abstract available for this presentation
-
+
MS29.03 - Polygenic Risk Score for Risk Assessment
14:05 - 14:20 | Presenter: Rayjean J. Hung | Author(s): Yonathan Brhane, Nilanjan Chatterjie, David C Christiani, Neil Caporaso, Maria Teresa Landi, Loic Le Marchand, Geoffrey Liu, Stephen Lam, John Kirkpatrick Field, Paul Brennan, Christopher Ian Amos
- Abstract
No abstract available for this presentation
-
+
MS29.04 - LuCID Exhaled Breath Analysis
14:20 - 14:35 | Presenter: Marc Phillipe Van Der Schee | Author(s): Edoardo Gaude, Jasper Boschmans, Billy Boyle, Robert Campbell Rintoul, Robert Smith, Anna Battista
- Abstract
No abstract available for this presentation
-
+
MS29.05 - Early Detection Biomarker Development: Is Success on the Horizon?
14:35 - 14:50 | Presenter: Peter Mazzone
- Abstract
No abstract available for this presentation
-
+
MS29.06 - Q&A
14:50 - 15:00
- Abstract
No abstract available for this presentation
-
+
MS30 - Modern Day RT in LA NSCLC: Where Is the Evidence?
- 13:30 - 15:00
- 9/26/2018
- Location: Room 202 BD
- Type: Mini Symposium
- Track: Treatment of Locoregional Disease - NSCLC
-
+
MS30.01 - Introduction with Poll Questions
13:30 - 13:35 | Presenter: Fiona Hegi-Johnson, Yuko Nakayama
- Abstract
No abstract available for this presentation
-
+
MS30.01 - Overview of RT Technology in LA NSCLC (IMRT, VMAT, IGRT)
13:35 - 13:50 | Presenter: Gerard G Hanna
- Abstract
No abstract available for this presentation
-
+
MS30.02 - What Evidence Is Available to Support RT Technology in LA NSCLC (including Protons)?
13:50 - 14:05 | Presenter: Yong Chan Ahn
- Abstract
No abstract available for this presentation
-
+
MS30.03 - What Evidence Is Available to Support RT Treatment Intensification in LA NSCLC?
14:05 - 14:20 | Presenter: Jeffrey Bradley
- Abstract
No abstract available for this presentation
-
+
MS30.04 - Perspective
14:20 - 14:35 | Presenter: Maria Werner-Wasik
- Abstract
No abstract available for this presentation
-
+
MS30.05 - Nutritional Management During Radical Radiotherapy
14:35 - 14:50 | Presenter: Rhys White
- Abstract
No abstract available for this presentation
-
+
MS30.06 - Q&A with Poll Questions
14:50 - 15:00
- Abstract
No abstract available for this presentation
-
+
MS31 - Clinical Science in Mesothelioma
- 13:30 - 15:00
- 9/26/2018
- Location: Room 205 AC
- Type: Mini Symposium
- Track: Mesothelioma
-
+
MS31.01 - Mechanisms and Targets for BAP1 Activity
13:30 - 13:45 | Presenter: Michele Carbone
- Abstract
No abstract available for this presentation
-
+
MS31.02 - Clinical Implementation of BAP1 Inhibitors
13:45 - 14:00 | Presenter: Paul Baas | Author(s): Laurel Schunselaar
- Abstract
No abstract available for this presentation
-
+
MS31.03 - Targeting the Hippo Pathway
14:00 - 14:15 | Presenter: David Mark Jablons | Author(s): Gavitt A. Woodard
- Abstract
No abstract available for this presentation
-
+
MS31.04 - CAR-T and ADC's in MPM
14:15 - 14:30 | Presenter: Prasad S. Adusumilli
- Abstract
No abstract available for this presentation
-
+
MS31.05 - Vaccination and Antibody-Based Therapy in Mesothelioma
14:30 - 14:45 | Presenter: Joachim G.J.V. Aerts
- Abstract
No abstract available for this presentation
-
+
MS31.06 - Q&A
14:45 - 15:00
- Abstract
No abstract available for this presentation
-
+
MS32 - SCLC - From Benchside to Bedside - Clinical Science Session
- 13:30 - 15:00
- 9/26/2018
- Location: Room 107
- Type: Mini Symposium
- Track: Small Cell Lung Cancer/NET
-
+
MS32.01 - Genetic Mouse Models (GEMMS)
13:30 - 13:45 | Presenter: Trudy G Oliver | Author(s): Gurkan Mollaoglu, Milind Chalishazar, Fang Huang, Matthew Guthrie, Stefanie Bohm, Johannes Breagelmann, Triparna Sen, Lauren Byers, Jane Johnson, Robert Wechsler-Reya, Adi Gazdar, Ralph Deberardinis, Martin L Sos
- Abstract
No abstract available for this presentation
-
+
MS32.02 - Patient Derived Models (PDX & CTC-Derived)
13:45 - 14:00 | Presenter: Anna F. Farago
- Abstract
No abstract available for this presentation
-
+
MS32.03 - Liquid Biopsies for Drug Development in SCLC
14:00 - 14:15 | Presenter: Caroline Dive | Author(s): Ged Brady, Dominic Rothwell, Kristopher Frese, Kathryn Simpson, Jacqueline Pierce, Elaine Kilgour, Fiona Blackhall
- Abstract
No abstract available for this presentation
-
+
MS32.04 - Molecular Phenotypes of SCLC
14:15 - 14:30 | Presenter: Adi Gazdar
- Abstract
No abstract available for this presentation
-
+
MS32.05 - Targeting DNA Damage and Repair
14:30 - 14:45 | Presenter: Lauren Byers
- Abstract
No abstract available for this presentation
-
+
MS32.06 - Epigenetic Targets
14:45 - 15:00 | Presenter: John Poirier
- Abstract
No abstract available for this presentation
-
+
PL04 - Take Action - Key Messages from WCLC 2018 and Goals for 2019
- 15:15 - 16:30
- 9/26/2018
- Location: Plenary Hall
- Type: Plenary Session
- Track:
-
+
PL04.01 - Immunotherapy
15:15 - 15:25 | Presenter: David R. Gandara
- Abstract
No abstract available for this presentation
-
+
PL04.02 - Biomarkers
15:25 - 15:35 | Presenter: Ming Sound Tsao
- Abstract
No abstract available for this presentation
-
+
PL04.03 - Surgery
15:35 - 15:45 | Presenter: Ramon Rami-Porta
- Abstract
No abstract available for this presentation
-
+
PL04.04 - Radiation Oncology
15:45 - 15:55 | Presenter: Jose Belderbos
- Abstract
No abstract available for this presentation
-
+
PL04.05 - Clinical Research in Latin America
15:55 - 16:05 | Presenter: Clarissa Mathias
- Abstract
No abstract available for this presentation
-
+
PL04.06 - Targeted Therapy
16:05 - 16:15 | Presenter: Michael Boyer
- Abstract
No abstract available for this presentation
-
+
PL04.07 - Discussion and Q&A
16:15 - 16:25
- Abstract
No abstract available for this presentation
-
+
PL04.08 - Invitation to WCLC 2019 Barcelona, Spain
16:25 - 16:30
- Abstract
No abstract available for this presentation